Limits...
A novel technique for quantifying changes in vascular density, endothelial cell proliferation and protein expression in response to modulators of angiogenesis using the chick chorioallantoic membrane (CAM) assay.

Miller WJ, Kayton ML, Patton A, O'Connor S, He M, Vu H, Baibakov G, Lorang D, Knezevic V, Kohn E, Alexander HR, Stirling D, Payvandi F, Muller GW, Libutti SK - J Transl Med (2004)

Bottom Line: Reliable quantitative evaluation of molecular pathways is critical for both drug discovery and treatment monitoring.This improved CAM assay can correlate changes in vascular density with changes seen on a molecular level.We expect that these described modifications will result in a single in vivo assay system, which will improve the ability to investigate molecular mechanisms underlying the angiogenic response.

View Article: PubMed Central - HTML - PubMed

Affiliation: Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. Steven_Libutti@nih.gov

ABSTRACT
Reliable quantitative evaluation of molecular pathways is critical for both drug discovery and treatment monitoring. We have modified the CAM assay to quantitatively measure vascular density, endothelial proliferation, and changes in protein expression in response to anti-angiogenic and pro-angiogenic agents. This improved CAM assay can correlate changes in vascular density with changes seen on a molecular level. We expect that these described modifications will result in a single in vivo assay system, which will improve the ability to investigate molecular mechanisms underlying the angiogenic response.

No MeSH data available.


LES/LM609 pathway. (A) Alpha v beta 3 staining was most intense in stimulated CAM disks. The difference in staining was found to be statistically significant between stimulated CAM disks and disks treated with fumagillin (P = 0.01, Student's t test). (B) Cleaved caspase-3 staining was found to be greatest in stimulated disks treated with carrier solution and least in CAM disks treated with fumagillin (P = 0.007, Student's t test) and LM609 (P = 0.014, Student's t test).
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC373457&req=5

Figure 5: LES/LM609 pathway. (A) Alpha v beta 3 staining was most intense in stimulated CAM disks. The difference in staining was found to be statistically significant between stimulated CAM disks and disks treated with fumagillin (P = 0.01, Student's t test). (B) Cleaved caspase-3 staining was found to be greatest in stimulated disks treated with carrier solution and least in CAM disks treated with fumagillin (P = 0.007, Student's t test) and LM609 (P = 0.014, Student's t test).

Mentions: The amount of alpha v beta3 staining was greatest in stimulated CAM disks treated with bFGF. There was a significant decrease in the amount of alpha v beta3 in CAM disks after systemic treatment with fumagillin (P = 0.01, Student's T test). Treatment with LM609 did not significantly reduce the expression of alpha v beta 3 (P = 0.1376, Alternate Welch t test) although the values trended lower than control. Finally, there was a significant decrease in the amount of cleaved caspase 3 in CAM disks after systemic treatment with fumagillin (P = 0.007, Student's t test) and LM609 (P = 0.014, Student's t test, Figure 5B). This finding is consistent with previous data demonstrating a relationship between fumagillin treatment and inhibition of cleaved caspase-3 [14].


A novel technique for quantifying changes in vascular density, endothelial cell proliferation and protein expression in response to modulators of angiogenesis using the chick chorioallantoic membrane (CAM) assay.

Miller WJ, Kayton ML, Patton A, O'Connor S, He M, Vu H, Baibakov G, Lorang D, Knezevic V, Kohn E, Alexander HR, Stirling D, Payvandi F, Muller GW, Libutti SK - J Transl Med (2004)

LES/LM609 pathway. (A) Alpha v beta 3 staining was most intense in stimulated CAM disks. The difference in staining was found to be statistically significant between stimulated CAM disks and disks treated with fumagillin (P = 0.01, Student's t test). (B) Cleaved caspase-3 staining was found to be greatest in stimulated disks treated with carrier solution and least in CAM disks treated with fumagillin (P = 0.007, Student's t test) and LM609 (P = 0.014, Student's t test).
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC373457&req=5

Figure 5: LES/LM609 pathway. (A) Alpha v beta 3 staining was most intense in stimulated CAM disks. The difference in staining was found to be statistically significant between stimulated CAM disks and disks treated with fumagillin (P = 0.01, Student's t test). (B) Cleaved caspase-3 staining was found to be greatest in stimulated disks treated with carrier solution and least in CAM disks treated with fumagillin (P = 0.007, Student's t test) and LM609 (P = 0.014, Student's t test).
Mentions: The amount of alpha v beta3 staining was greatest in stimulated CAM disks treated with bFGF. There was a significant decrease in the amount of alpha v beta3 in CAM disks after systemic treatment with fumagillin (P = 0.01, Student's T test). Treatment with LM609 did not significantly reduce the expression of alpha v beta 3 (P = 0.1376, Alternate Welch t test) although the values trended lower than control. Finally, there was a significant decrease in the amount of cleaved caspase 3 in CAM disks after systemic treatment with fumagillin (P = 0.007, Student's t test) and LM609 (P = 0.014, Student's t test, Figure 5B). This finding is consistent with previous data demonstrating a relationship between fumagillin treatment and inhibition of cleaved caspase-3 [14].

Bottom Line: Reliable quantitative evaluation of molecular pathways is critical for both drug discovery and treatment monitoring.This improved CAM assay can correlate changes in vascular density with changes seen on a molecular level.We expect that these described modifications will result in a single in vivo assay system, which will improve the ability to investigate molecular mechanisms underlying the angiogenic response.

View Article: PubMed Central - HTML - PubMed

Affiliation: Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. Steven_Libutti@nih.gov

ABSTRACT
Reliable quantitative evaluation of molecular pathways is critical for both drug discovery and treatment monitoring. We have modified the CAM assay to quantitatively measure vascular density, endothelial proliferation, and changes in protein expression in response to anti-angiogenic and pro-angiogenic agents. This improved CAM assay can correlate changes in vascular density with changes seen on a molecular level. We expect that these described modifications will result in a single in vivo assay system, which will improve the ability to investigate molecular mechanisms underlying the angiogenic response.

No MeSH data available.